- Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma: results of a Minnie Pearl Cancer Research Network phase II trial. Meluch, A.A., Greco, F.A., Morrissey, L.H., Raefsky, E.L., Steis, R.G., Butts, J.A., Hainsworth, J.D. Cancer (2003)